CRISPR as a suicide pill for cancer cells. “In bacteria, this CRISPR acts as a suicide pill, intentionally killing a cell that has been infected by a virus to prevent its spread.” Researchers reengineered that idea so once a cell […]
“The new technique lets scientists study the effects of perturbing over 20,000 genes on hundreds of image-based cellular features. Generating data with the method is more than 10 times less expensive than comparable high-dimensional approaches such as high-throughput single-cell RNA […]
This is an interview with the Nobel prize winner about her current scientific pursuit of microbiome therapies. “Well, it’s become more and more clear that we are our microbiome. And that’s only become clear in the last, I don’t know, […]
“The company, based in Cambridge, Massachusetts, has developed a technique that uses the gene-editing tool CRISPR to make around 70 edits to a pig’s genome. These edits should allow the organs to be successfully transplanted into people, the team says. […]
“A new study unexpectedly found prairie voles genetically modified to carry no oxytocin receptors still formed strong social bonds and retained the ability to nurse offspring” ~ learn more
“It is probably the most complicated therapy ever attempted in the clinic,” says study co-author Antoni Ribas, a cancer researcher and physician at the University of California, Los Angeles. “We’re trying to make an army out of a patient’s own […]
In the past they’ve taken cells out, edited them in a lab, then put them back. This time, researchers engineered a virus to make the edits directly inside the patient to fix blindness. “They hope to know within weeks whether […]
“An exciting new study has demonstrated how a new kind of CRISPR technique can increase the expression of certain genes, instead of the more traditional approach of cutting or editing DNA. The method was tested in mice, targeting genes associated […]
ARK Invest summarizes how various companies are working to apply the technology across different applications. This is a great shapshot of the investment opportunities in CRISPR right now. | learn more
“The CRISPR gene editing revolution is less than a decade old and scientists are still learning how best to deploy this ground-breaking technique. A team has recently discovered why the technique sometimes fails, uncovering a novel insight that will hopefully […]